Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5647245 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 11 Pages |
Abstract
Most ALEs after immunization are not suggestive of anaphylaxis and should not be managed as such. The definition of anaphylaxis in the JTFPP guidelines is nonspecific and may need to be revisited. Restricting skin testing and graded dose reimmunization to patients whose ALE onset is â¤1 hour (compatible with IgE-mediated reaction) and to those meeting specific clinical criteria for anaphylaxis (whatever the timing) is likely a sufficiently sensitive and cautious approach.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Joseline G. MD, MPH, Gaston MD, PhD, Isabelle PhD, Marie-Claude MSc, Rémi MD, FRCPC, Jean-Philippe MD, FRCPC, Danuta M. MD, FRCPC,